Part 1 Overview of Dengue What Is Dengue WHO Dengue Case Classification Prevalence and Disease Burden of Dengue Dengue Serotypes Global Distribution of Dengue 2012 Global Dengue Transmission Map Thailand ID: 697153
Download Presentation The PPT/PDF document "Dengue Prevention in Asia" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Dengue Prevention in AsiaSlide2
Part 1:
Overview of DengueSlide3
What Is Dengue?Slide4
WHO Dengue Case ClassificationSlide5
Prevalence and Disease Burden of DengueSlide6
Dengue SerotypesSlide7
Global Distribution of Dengue, 2012Slide8
Global Dengue Transmission Map - ThailandSlide9
Social Impact of Dengue Slide10
Asymptomatic Individuals and TransmissionSlide11
Getting Dengue More Than OnceSlide12
Why Does Severe Dengue Occur?Slide13
Prevention of Dengue InfectionSlide14
Dengue CYD-TDVSlide15
Efficacy of CYD-TDVSlide16
Efficacy of CYD-TDV (cont)Slide17
Part 2:
Dengue Q&ASlide18
Question: Why is the dengue vaccine not recommended in children aged < 9 years? Slide19
Vaccination Age RecommendationsSlide20
Question: What did the WHO recommend in July 2016 for countries considering introducing the CYD-TDV?Slide21
WHO Recommendation, July 2016Slide22
Question: What did the additional analysis provided to WHO conclude?Slide23
Results of Additional Analysis of Dengue Vaccine DataSlide24
Question: Why is there a higher risk of severe dengue in seronegative people who receive the vaccine?Slide25
Higher Severe Dengue Risk in Seronegative People Who Receive the VaccineSlide26
Higher Severe Dengue Risk in Seronegative People Who Receive the Vaccine (cont)Slide27
Question: What happens to people who have breakthrough dengue after being vaccinated?Slide28
Breakthrough Dengue After VaccinationSlide29
Question: Has the WHO updated it position as a result of this analysis?Slide30
Updated WHO Position, December 2017Slide31
Question: Why did the vaccine manufacturer request a label update in November 2017?Slide32
Vaccine Label Update RequestSlide33
Question: Why have some countries recently begun re-examining their use of dengue vaccine?Slide34
Re-Examination of Vaccine Use in AsiaSlide35
Question: Are people previously infected with dengue likely to know that they had the disease?Slide36
Awareness of Previous Dengue InfectionSlide37
Question: How can a physician determine whether or not a patient should receive the vaccine?Slide38
Deciding Whether to VaccinateSlide39
Questions from patients and parentsSlide40
Considerations When Vaccinating ChildrenSlide41
Other ConsiderationsSlide42
Vaccine Side EffectsSlide43
SummarySlide44